fbpx

Telehealth Companies Applaud DEA For Delaying Telemedicine Restrictions Of Controlled Substances

The Drug Enforcement Administration received 38,000 comments on its proposed rule that would roll back COVID-19 flexibilities for the prescribing of controlled substances via telemedicine. In response, the DEA chose to temporarily extend the flexibilities.

The post Telehealth Companies Applaud DEA For Delaying Telemedicine Restrictions Of Controlled Substances appeared first on Above the Law.

Related Articles

Responses

Your email address will not be published. Required fields are marked *